Cameron Daye Memorial Golf Invitational 2022

Cameron Daye Memorial Golf Invitational 2022 supporting Alberta Cancer Foundation
Cameron Daye Memorial Golf Invitational 2022

About Cameron Daye Memorial Golf Invitational 2022

Dear friends and colleagues,

I would like to talk to you about a fundraising initiative that is close to my heart.

As you may be aware, my son Cameron passed away from sarcoma. Sarcoma is a rare form of cancer that affects the body’s “connective tissues” including nerves, muscles, joints, bone, fat and blood vessels. Sarcoma affects people of all ages, but is more prevalent in children and young adults.

To make life better for sarcoma patients, more research is needed. My family and I have been working with the Alberta Cancer Foundation to raise funds specifically for full-time resources for sarcoma research to be available through an endowment. Together, we will create more moments for sarcoma patients across the province.

Every donation, large or small will make a difference!

How can you help? We will accept cash and cheque donations online, via this website, as well as in the Rangeland office; please see Sandy Riediger for details. We will also be holding events throughout the year where you will have the opportunity to donate and participate.

Your generosity and large hearts have been very much appreciated in the past. Your continued support means so very much to my family and to allAlbertans facing cancer.

Thank you,
Ron Daye

Interested in sponsoring our 2022 Cameron Daye Memorial Golf Invitational? Contact us!

Sandy Riediger


Starts at:  August 20, 2022 1:00 AM
Ends at:  August 20, 2022 1:00 AM


Turney Valley Golf Club


Sandy Riediger

Dollars at Work

Every year, 150 Albertans are diagnosed with sarcoma, with children and young adults disproportionately accounting 15 per cent of cases.

In the summer of 2019, Rangeland Engineering partnered with the Alberta Cancer Foundation on the creation of the Cameron Daye and Catherine Pearson Sarcoma Fellowship Fund. Valued at approximately $2.7 million, the fund will be put toward groundbreaking sarcoma research initiatives. Funds will be spent on projects in Alberta — one of the first is immunotherapy treatment research, conducted by Dr. Michael Monument at the University of Calgary’s Cumming School of Medicine — across Canada and abroad. 

Click here to learn more.